Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.

Susana ArmestoCarmen González VelaJulia SánchezAitziber IllaroJesús MayorgaAna E López SundhCristina Naharro FernándezNatalia PalmouCristina Gómez-FernándezMarcos A González LópezMiguel A González-Gay

Published in: Dermatologic therapy (2020)

Keyphrases

combination therapy
multidrug resistant
drug resistant
gram negative
acinetobacter baumannii
high dose
klebsiella pneumoniae
atopic dermatitis
low dose